Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Royer-Perron

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Presse Medicale (Paris, France : 1983)|November 13, 2018
Management of primary central nervous system lymphomaLouis Royer-Perron, Khê Hoang-Xuan
La Revue Du Praticien|December 5, 2018
[Primary central nervous system lymphoma]Louis Royer-Perron, Khê Hoang-Xuan, Caroline Houillier
Current Opinion in Neurology|September 19, 2017
Primary central nervous system lymphoma: time for diagnostic biomarkers and biotherapies?Louis Royer-Perron, Khê Hoang-Xuan, Agusti Alentorn
Current Pharmaceutical Design|October 28, 2017
Seizures and Anticonvulsants in Brain Tumours: Frequency, Mechanisms and Anti-Epileptic ManagementCharles Vecht, Louis Royer-Perron, Caroline Houillier, et al.
The Oncologist|March 15, 2019
Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System LymphomasMy Le, Ytel Garcilazo, Maria-José Ibáñez-Juliá, et al.
Blood Cells, Molecules & Diseases|December 4, 2018
Primary CNS lymphoma patient-derived orthotopic xenograft model capture the biological and molecular characteristics of the diseaseFrédéric Pouzoulet, Agusti Alentorn, Louis Royer-Perron, et al.
Neuro-Oncology|February 13, 2018
Identification of novel recurrent ETV6-IgH fusions in primary central nervous system lymphomaAurélie Bruno, Karim Labreche, Maïlys Daniau, et al.
Neuro-Oncology|May 19, 2019
A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network studyKarim Labreche, Mailys Daniau, Amit Sud, et al.
Clinical and Translational Medicine|July 9, 2022
Identification of growth hormone receptor as a relevant target for precision medicine in low-EGFR expressing glioblastomaMaïté Verreault, Irma Segoviano Vilchis, Shai Rosenberg, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Presse Medicale (Paris, France : 1983)|November 13, 2018
Management of primary central nervous system lymphomaLouis Royer-Perron, Khê Hoang-Xuan
La Revue Du Praticien|December 5, 2018
[Primary central nervous system lymphoma]Louis Royer-Perron, Khê Hoang-Xuan, Caroline Houillier
Current Opinion in Neurology|September 19, 2017
Primary central nervous system lymphoma: time for diagnostic biomarkers and biotherapies?Louis Royer-Perron, Khê Hoang-Xuan, Agusti Alentorn
Current Pharmaceutical Design|October 28, 2017
Seizures and Anticonvulsants in Brain Tumours: Frequency, Mechanisms and Anti-Epileptic ManagementCharles Vecht, Louis Royer-Perron, Caroline Houillier, et al.
The Oncologist|March 15, 2019
Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System LymphomasMy Le, Ytel Garcilazo, Maria-José Ibáñez-Juliá, et al.
Blood Cells, Molecules & Diseases|December 4, 2018
Primary CNS lymphoma patient-derived orthotopic xenograft model capture the biological and molecular characteristics of the diseaseFrédéric Pouzoulet, Agusti Alentorn, Louis Royer-Perron, et al.
Neuro-Oncology|February 13, 2018
Identification of novel recurrent ETV6-IgH fusions in primary central nervous system lymphomaAurélie Bruno, Karim Labreche, Maïlys Daniau, et al.
Neuro-Oncology|May 19, 2019
A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network studyKarim Labreche, Mailys Daniau, Amit Sud, et al.
Clinical and Translational Medicine|July 9, 2022
Identification of growth hormone receptor as a relevant target for precision medicine in low-EGFR expressing glioblastomaMaïté Verreault, Irma Segoviano Vilchis, Shai Rosenberg, et al.
Pageof 1